期刊文献+

THE EFFECT OF THE TRANSFER OF LAK CELLS, COMBINED WITH ALLOIMMUNIZATION, ON THE PULMONARY METASTASES OF RAT MAMMARY CARCINOMA

THE EFFECT OF THE TRANSFER OF LAK CELLS, COMBINED WITH ALLOIMMUNIZATION, ON THE PULMONARY METASTASES OF RAT MAMMARY CARCINOMA
下载PDF
导出
摘要 Alloimmunization was combined with lympho-kine activated killer (LAK) cells to assess its effect on mammary carcinoma in rats. The animals were injected with both irradiated allosplenocytes and syngeneic LAK cells. Metastatic lung nodules were markedly reduced using combined therapy when compared with the transfer of LAK cells or alloimmuni-zation alone. IL-2 activity in the serum of alloim-munized rats could be detected. This activity, maintained in vivo for one week, may be responsible for enhancing the antitumor effect of transferred LAK cells. Alloimmunization was combined with lympho-kine activated killer (LAK) cells to assess its effect on mammary carcinoma in rats. The animals were injected with both irradiated allosplenocytes and syngeneic LAK cells. Metastatic lung nodules were markedly reduced using combined therapy when compared with the transfer of LAK cells or alloimmuni-zation alone. IL-2 activity in the serum of alloim-munized rats could be detected. This activity, maintained in vivo for one week, may be responsible for enhancing the antitumor effect of transferred LAK cells.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1989年第1期16-19,共4页 中国癌症研究(英文版)
  • 相关文献

参考文献12

  • 1Ba Denian,et al.Antimetastatic activity of LAK cells to rat fibrosarcoma (WBT-2M) and rat mammary carcinoma (SST-2). Chinese Medical Journal . 1987
  • 2Grimm EA,et al.Lymphokine-activated killer cells phenomenon. The Journal of Experimental Medicine . 1982
  • 3Mule JJ,et al.Antitumor efficacy of lymphokine-activavted killer cells and recombinant interleukin 2 in vivo: Survival benefit and mechanism of tumor escape in mice undergoing immunotherapy. Cancer Research . 1986
  • 4Wofsy D.57</sub> BL/6 mice bearing the lpr gene&amp;sid=The Journal of Experimental Medicine&amp;aufirst=Wofsy D');&#xA; ">Deficient interleukin 2 activity in MRL-IMP and C<sub>57</sub> BL/6 mice bearing the lpr gene. The Journal of Experimental Medicine . 1982
  • 5Muie JJ,et al.Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin 2. Science . 1984
  • 6Lattime EC,Stutman O.The generation of culture activated killer cells (AK) is interleukin-2-dependent and requires self-la recognition. International Journal of Cancer . 1985
  • 7Lotze MT,et al.In vivo administration of purified human interleukin 2 Ⅱ.Half life,immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL-2. J Immunol . 1985
  • 8Jacobs SK,et al.Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: Phase I trial. Cancer Research . 1986
  • 9Rosenberg SA.A progress report on the treatment of 157 patients with advanced cancer using LAK cells and IL-2 or high dose IL-2 alone. The New England Journal of Medicine . 1987
  • 10Gillis S.Biochemical characterization of lymphocyte regulatory molecules 11.Purification of a class of rats and human lymphokines. J Immunol . 1980

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部